Tempus AI, Inc. (NASDAQ:TEM) CFO James William Rogers Sells 83,025 Shares

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) CFO James William Rogers sold 83,025 shares of the company's stock in a transaction that occurred on Wednesday, December 11th. The shares were sold at an average price of $42.30, for a total value of $3,511,957.50. Following the completion of the sale, the chief financial officer now directly owns 231,280 shares in the company, valued at approximately $9,783,144. The trade was a 26.42 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Tempus AI Price Performance

NASDAQ TEM traded down $0.99 on Friday, reaching $41.00. The company's stock had a trading volume of 5,041,241 shares, compared to its average volume of 1,427,998. The business has a 50 day moving average price of $52.88. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. Tempus AI, Inc. has a twelve month low of $22.89 and a twelve month high of $79.49.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on TEM. Loop Capital upped their price objective on shares of Tempus AI from $48.00 to $57.00 and gave the company a "buy" rating in a research note on Tuesday, October 15th. Piper Sandler restated a "neutral" rating and set a $70.00 price objective (up previously from $40.00) on shares of Tempus AI in a report on Tuesday, November 12th. Wolfe Research assumed coverage on Tempus AI in a research note on Friday. They issued an "outperform" rating and a $60.00 target price for the company. Bank of America increased their target price on Tempus AI from $52.00 to $54.00 and gave the stock a "neutral" rating in a research report on Friday. Finally, Stifel Nicolaus downgraded shares of Tempus AI from a "buy" rating to a "hold" rating and upped their price objective for the company from $45.00 to $65.00 in a research note on Monday, November 11th. Three research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $56.00.

Institutional Investors Weigh In On Tempus AI

A number of large investors have recently made changes to their positions in TEM. First Horizon Advisors Inc. acquired a new position in Tempus AI in the 3rd quarter worth about $30,000. Vestor Capital LLC bought a new stake in shares of Tempus AI in the 3rd quarter valued at approximately $153,000. Stifel Financial Corp acquired a new position in Tempus AI in the third quarter worth approximately $218,000. Sandia Investment Management LP acquired a new position in Tempus AI in the second quarter worth approximately $136,000. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd bought a new position in Tempus AI during the third quarter valued at approximately $258,000. Institutional investors and hedge funds own 24.22% of the company's stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.